Skin aging is driven by a combination of intrinsic biological processes and external environmental factors, leading to loss of collagen, reduced elasticity, uneven pigmentation, and impaired tissue regeneration. DermExo is designed to target these mechanisms at the cellular level.

Therapeutic Rationale

Extracellular vesicles carry bioactive proteins, lipids, and nucleic acids that play a critical role in cell-to-cell communication and tissue repair. DermExo leverages these properties to stimulate natural regenerative pathways in the skin.

• • Activation of collagen and elastin production
• • Enhancement of skin cell regeneration and repair
• • Reduction of inflammation and oxidative stress
• • Improvement of skin barrier function and hydration

Potential Benefits

DermExo is being developed to deliver visible and long-term aesthetic benefits, including:

• • Improved skin texture, tone, and elasticity
• • Reduction in fine lines, wrinkles, and signs of aging
• • Enhanced skin brightness and uniform appearance
• • Accelerated skin recovery and rejuvenation

Development Focus

DermExo is part of RCT’s regenerative dermatology and aesthetic pipeline. Current development efforts focus on formulation optimization, safety assessment, and validation of biological activity for cosmetic and aesthetic applications.